On April 1, 2021 Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, reported it will collaborate with the Melanoma Research Foundation (MRF) to present "Ask the Expert" Managing Melanoma, a webinar series, throughout the month of April (Press release, Castle Biosciences, APR 1, 2021, View Source [SID1234577514]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The MRF is the largest independent organization dedicated to melanoma research, education of patients and their caregivers and advocacy on both the federal and state-level. The "Ask the Expert" Managing Melanoma series is aimed at increasing awareness and engagement in the melanoma community and will feature leading dermatologists and melanoma experts.
The Facebook Live webinars are accessible to the public and will take place on the MRF Facebook page with the following industry leaders:
April 6, 2021 @ 3 p.m. E.T.: Abel Jarrell, M.D., dermatology/dermatopathology, Melanoma Patient Journey
April 13, 2021 @ 4 p.m. E.T.: Brent Moody, M.D., Mohs surgeon, Familial Genetics vs. Tumor Genetics
April 20, 2021 @ 4 p.m. E.T.: Shannon Trotter, D.O., dermatology, Use of Gene Expressing Profiling in Melanoma Prognosis
April 27, 2021 @ 3 p.m. E.T.: Steven Trocha, M.D., surgical oncologist, Lifetime Clinic for High-Risk Melanoma Patients
"Disease awareness, preventive methods and early detection are all key factors that contribute to the best patient outcomes," said Derek Maetzold, president and chief executive officer of Castle Biosciences. "We are proud to support the MRF and its ‘Ask the Expert’ sessions to provide additional resources for patients and educate the public on melanoma and on the role of tumor biology and genomic testing in informing cancer treatment plan decisions for this aggressive form of skin cancer."
"Our mission is to prevent melanoma in as many people as possible," said Kyleigh Lipira, M.B.A., chief executive officer of the MRF. "Our work with Castle complements our goal of providing the necessary insight and resources to vigilantly prevent and detect melanoma."
For more information on the "Ask the Expert" Facebook Live webinars, or to access a recorded playback of the sessions, please visit the MRF Facebook page here.